Foghorn Therapeutics Inc (NAS:FHTX)
$ 6.67 -0.15 (-2.19%) Market Cap: 396.40 Mil Enterprise Value: 272.81 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 67/100

Foghorn Therapeutics Inc. at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 06:15PM GMT
Release Date Price: $7.57 (+2.99%)
Vikram Purohit
Morgan Stanley & Co LLC - Analyst

All right, welcome, everyone. Thanks for joining. My name is Vikram Purohit, I'm one of the biotech analysts with the research team. This is the fireside chat with Foghorn Therapeutics.

Before we kick it off, I just need to read a brief disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

With that, I'm very happy to have with me the CEO of Foghorn, Adrian Gottschalk. I said that correctly?

Adrian Gottschalk
Foghorn Therapeutics Inc - President & CEO

You get it right every year.

Vikram Purohit;Adrian Gottschalk
Morgan Stanley & Co LLC - Analyst;Foghorn Therapeutics Inc - President

Okay. Thanks for joining us. Appreciate it.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot